Latest Report
Available at Orbis research Biosimilars Market provides pin-point analysis for
changing competitive dynamics and a forward looking perspective on different
factors driving or restraining industry growth.
Request sample
copy of this report @ http://www.orbisresearch.com/contacts/request-sample/219789 .
The Global Biosimilars Market was valued at USD 5237.0 currently and is
projected to reach USD 28200.0 million by 2020, at a CAGR of 40.3% during the
forecast period from 2015 to 2021.
The global biosimilars market is segmented on the basis of technology,
product, application, service, and geography. The technology segment is further
divided into Monoclonal Antibody Technology and Recombinant DNA Technology; the
product segment into Peptides, Recombinant Non-Glycosylated Proteins and
Recombinant Glycosylated Proteins; the application segment into Growth Hormone
Deficiency, Oncology Diseases, Autoimmune disorders, Blood Disorders; and the
Services segment into Contract Manufacturing Organizations, Contract Research
Organizations and Academia. On the basis of geography, the report has been
segmented into North America (U.S., Canada, Mexico), Europe (U.K, Germany,
France, Italy, Spain) , Asia-Pacific (India, China, Japan, Australia), and the
Rest of the World.
The factors that are contributing to the growth of this market are the
intended reductions in the healthcare expenditure, cost-effectiveness of
biosimilar drugs, and the increasing number of off-patented drugs whose total sales
in the year 2013 was USD 9.1 billion will expire in 2018 and 2016 in the EU and
the US, respectively. Similarly, six such multi-billion drugs will expire in
coming five years. Other than these, the rising demand for biosimilars is also
another driving force for the biosimilars market.
However, there are factors that are restraining the growth of this market, such as the different regulatory frameworks and requirements in different countries and high manufacturing complexities, since the manufacturing of biosimilars requires sophisticated technologies. Although, small scale production is quite possible, but there is a risk involved in the scaling-up of the production. This brings forward the concern of operating on a large scale.
The major players of this market are Sandoz, Dr. Reddys, Teva
Pharmaceuticals, Hospira, Bioton, Biocon, Sun-Ranbaxy, Zydus Cadila, Synthon,
and Celltrion. This report offers comprehensive profiles of these companies
composed of their business strategy for biosimilars.
Purchase a copy
of Biosimilars Market visit @ http://www.orbisresearch.com/contact/purchase/219789
For more information contact sales@orbisresearch.com .
Key Deliverables
in the Report:
Global, regional and country-level analysis along with forecasts of the study market
Study of the effect of exogenous & endogenous factors, viz. demographic, economics, and political factors, among others, which affect the global market
Global, regional and country-level analysis along with forecasts of the study market
Study of the effect of exogenous & endogenous factors, viz. demographic, economics, and political factors, among others, which affect the global market
Porterfive forces framework incorporating the factors influencing each
force to determine the intensity of competition
Segment and sub-segment level analysis of the market over the review and forecast period
Identification of key factors instrumental in changing the market scenario, exploiting new opportunities and gaining competitive edge
SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicators
Browse Complete
Report @ http://www.orbisresearch.com/reports/index/global-biosimilars-market-growth-trends-and-forecasts-2017-2022 .
Some points from TOC:
1. Introduction
1.1 Report Description
1.2 Research Methodology
1.1 Report Description
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Reductions healthcare expenditure
3.2.2 Cost-effectiveness
3.2.3 Increasing number of off-patented drugs
3.2.4 Rising demand for biosimilars
3.3 Market Restraints
3.3.1 Different regulatory frameworks and requirements in countries
3.3.2 High manufacturing complexities
3.4 Market Opportunitites
3.1 Market Definition
3.2 Market Drivers
3.2.1 Reductions healthcare expenditure
3.2.2 Cost-effectiveness
3.2.3 Increasing number of off-patented drugs
3.2.4 Rising demand for biosimilars
3.3 Market Restraints
3.3.1 Different regulatory frameworks and requirements in countries
3.3.2 High manufacturing complexities
3.4 Market Opportunitites
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
About Us:
Orbis Research (orbisresearch.com) is a single point aid
for all your market research requirements. We have vast database of reports
from the leading publishers and authors across the globe. We specialize in
delivering customized reports as per the requirements of our clients. We have
complete information about our publishers and hence are sure about the accuracy
of the industries and verticals of their specialization. This helps our clients
to map their needs and we produce the perfect required market research study
for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214)
884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment